Charting the growth of programmed cell death studies in uveal melanoma: a bibliometric evidence

This bibliometric study established a view of PCD research trends in uveal melanoma, demonstrating the field's rapid expansion, strong international collaborations, and an increasing emphasis on emerging cell-death pathways. These results underscore that deeper mechanistic insights into PCD processes have the potential to inform more effective therapies and prognostic tools, particularly in light of the limited treatment options once metastatic disease occurs. Early integration of PCD-focused hypotheses may support precision-medicine study design; however, bibliometrics cannot establish treatment benefit, and clinical trials are required to determine whether PCD-targeted strategies improve outcomes.

Authors

Institutions

Publication Details

Journal
Discover Oncology
Published
2025-12-22
DOI
https://doi.org/10.1007/s12672-025-04131-5
Primary Topic
Ocular Oncology and Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Charting the growth of programmed cell death studies in uveal melanoma: a bibliometric evidence

J. Zhang, Li Li
Discover Oncology
Ocular Oncology and Treatments
article

Charting the growth of programmed cell death studies in uveal melanoma: a bibliometric evidence

J. Zhang, Li Li
article en

Abstract

This bibliometric study established a view of PCD research trends in uveal melanoma, demonstrating the field's rapid expansion, strong international collaborations, and an increasing emphasis on emerging cell-death pathways. These results underscore that deeper mechanistic insights into PCD processes have the potential to inform more effective therapies and prognostic tools, particularly in light of the limited treatment options once metastatic disease occurs. Early integration of PCD-focused hypotheses may support precision-medicine study design; however, bibliometrics cannot establish treatment benefit, and clinical trials are required to determine whether PCD-targeted strategies improve outcomes.

Discover OncologyVol. 16(1)
Sichuan University (CN), West China Hospital of Sichuan University (CN)
Good health and well-being
Openalex Percentile: Top 30%
Ocular Oncology and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.